Evidence map›Paper›PMID 30518435›Full record

ArticleSystematic reviews2018

Bioactive scaffolds in stem-cell-based therapies for cardiac repair: protocol for a meta-analysis of randomized controlled preclinical trials in animal myocardial infarction models.

Kashif Khan, Karina Gasbarrino, Ibtisam Mahmoud, Georges Makhoul, Bin Yu, Line Dufresne, Stella S Daskalopoulou, Adel Schwertani, Renzo Cecere

Open access · goldAbstract read
In one paragraph

Article in Systematic reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Genome Editing and Cardiac Regeneration.Advances in experimental medicine and biology · 2023
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kashif KhanDivision of Cardiology and Cardiac Surgery, McGill University Health Centre, Montreal, Quebec, Canada.
Karina GasbarrinoDivision of Experimental Medicine, Department of Medicine, Faculty of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Ibtisam MahmoudMcConnell Resource Centre, McGill University Health Centre, Montreal, Quebec, Canada.
Georges MakhoulDivision of Cardiology and Cardiac Surgery, McGill University Health Centre, Montreal, Quebec, Canada.
Bin YuDivision of Cardiology and Cardiac Surgery, McGill University Health Centre, Montreal, Quebec, Canada.
Line DufresneDivision of Cardiology and Cardiac Surgery, McGill University Health Centre, Montreal, Quebec, Canada.
Stella S DaskalopoulouDivision of Experimental Medicine, Department of Medicine, Faculty of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Adel SchwertaniDivision of Cardiology and Cardiac Surgery, McGill University Health Centre, Montreal, Quebec, Canada.
Renzo CecereDivision of Cardiology and Cardiac Surgery, McGill University Health Centre, Montreal, Quebec, Canada. renzo.cecere@muhc.mcgill.ca.
McGill University Health Centre · CARoyal Victoria Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute myocardial infarction (MI) remains one of the leading causes of death worldwide with no curative therapy available. Stem cell therapies have been gaining interest as a means to repair the cardiac tissue after MI and prevent the onset of heart failure. Many in vivo reports suggest that the use of stem cells is promising, yet clinical trials suggest that the cells fail to integrate into the native tissue, resulting in limited improvements in cardiac function and repair. To battle this limitation, the combination of using stem cells embedded in a bioactive scaffold that promotes cell retention is growing in interest. Yet, a systematic review of the literature on the use of stem cells embedded in bioactive scaffolds for cardiac repair has not yet been performed. In this protocol, we outline a systematic review and meta-analysis of preclinical trials in animal MI models that utilize stem cell-embedded scaffolds for cardiac repair and compare their effects to stem cell-treated animals without the use of a scaffold. METHODS/

designWe will search the following electronic databases: Cochrane Library, MEDLINE, Embase, PubMed, Scopus and Web of Science, and gray literature: Canadian Agency for Drugs and Technologies in Health and Google Scholar. We will only include randomly controlled preclinical trials that have directly investigated the effects of stem cells embedded in a scaffold for cardiac repair in an animal MI model. Two investigators will independently review each article included in the final analysis. The primary endpoint that will be investigated is left ventricular ejection fraction. Secondary endpoints will include infarct size, end systolic volume, end diastolic volume, fractional shortening and left ventricular wall thickness. Pooled analyses will be conducted using the DerSimonian-Laird random effects and Mantel-Haenszel fixed-effect models. Between-studies heterogeneity will be quantified and determined using the Tau DISCUSSION: To date, the use of scaffolds in myocardial repair has not yet been systematically reviewed. The results of this meta-analysis will aid in determining the efficacy of stem cell-embedded scaffolds for cardiac repair and help bring this therapy to the clinic.

Indexed as

Disease Models, AnimalMyocardial InfarctionRandomized Controlled Trials as TopicStem Cell TransplantationTissue ScaffoldsAnimalsCardiac Surgical ProceduresHeart FailureHumansMeta-Analysis as TopicSystematic Reviews as TopicVentricular Function, LeftAnimalHydrogelMeta-analysisMyocardial infarctionPatchScaffoldStem cellsSystematic review

Identifiers

PMID30518435
PMCPMC6280361
OpenAlexW2902776406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.